Literature DB >> 2893206

Rapid alkalinisation for flavone acetic acid administration: a potentially hazardous procedure.

J Verweij, G Stoter, P Dodion, M Farinean.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2893206     DOI: 10.1016/s0140-6736(88)91200-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanoma.

Authors:  S B Kaye; M Clavel; P Dodion; S Monfardini; W ten Bokkel-Huinink; D T Wagener; S Gundersen; G Stoter; J Smith; J Renard
Journal:  Invest New Drugs       Date:  1990       Impact factor: 3.850

2.  Plasma pharmacokinetics of the antitumour agents 5,6-dimethylxanthenone-4-acetic acid, xanthenone-4-acetic acid and flavone-8-acetic acid in mice.

Authors:  M J McKeage; P Kestell; W A Denny; B C Baguley
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-dimethyl-xanthenone-4-acetic acid [correction of 5,6-methyl-] and flavone acetic acid.

Authors:  L M Ching; M J McKeage; W R Joseph; P Kestell; L J Zwi; B C Baguley
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer.

Authors:  B L Smith; M Bertagnolli; B B Klein; S Batter; M Chang; L M Douville; T J Eberlein
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

5.  An evaluation of the putative human mammary tumour retrovirus associated with peripheral blood monocytes.

Authors:  L P Kahl; A R Carroll; P Rhodes; J Wood; N G Read
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

6.  Breast cancer screening as public health policy in Finland.

Authors:  M Hakama; L Elovainio; R Kajantie; K Louhivuori
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.